PVmed (Perception Vision) is a groundbreaking startup in the healthcare industry, with a focus on driving innovations and changes in healthcare. Pioneering in medical technology, the company provides state-of-the-art customized solutions for the healthcare industry, with a primary focus on auxiliary diagnosis and treatment through self-developed AI-enhanced medical image processing systems. The company has established strategic partnerships with leading hospitals, research institutes, and device manufacturers globally, ensuring that its solutions are full clinical evidence-based and built on quality-labeled medical data and cutting-edge algorithms. These efforts are geared towards empowering physicians to deliver the highest standard of care to patients with consistency and efficiency.
Founded in
2017 and headquartered in
China, PVmed's current products include its Intelligent Radiationtherapy System and Intelligent Medical Image Post-processing System. The company recently secured a significant
CNY90.00M Series B investment on
01 February 2024, with the investment coming from
Zhuji Xienuo Xingshi Venture Capital Partnership. This investment is a testament to the confidence that investors have in PVmed's vision and potential for growth. With its innovative products and strategic partnerships, PVmed is at the forefront of advancing medical technology and improving patient care. For business or research inquiries, interested parties can reach out at
[email protected]. PVmed's commitment to leveraging technology for the betterment of healthcare positions it as an exciting prospect for investors looking to contribute to the evolution of the healthcare industry.